We analysed Ki67 and vimentin expression in CTC derived from a total of 144 advanced prostate cancer patients using CellSearch technology, optimized and validated to assay Ki67 and vimentin in separate patient cohorts. The gene discussed is MKI67; the disease is prostate cancer.